ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 164 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $87,000 | +3.6% | 1,130 | -31.1% | 0.71% | +38.4% |
| Q1 2018 | $84,000 | +10.5% | 1,640 | 0.0% | 0.51% | +6.9% |
| Q4 2017 | $76,000 | -12.6% | 1,640 | 0.0% | 0.48% | +200.0% |
| Q3 2017 | $87,000 | -14.7% | 1,640 | 0.0% | 0.16% | -18.0% |
| Q2 2017 | $102,000 | -8.1% | 1,640 | 0.0% | 0.19% | -13.8% |
| Q1 2017 | $111,000 | +141.3% | 1,640 | +148.5% | 0.22% | +129.6% |
| Q4 2016 | $46,000 | -99.9% | 660 | 0.0% | 0.10% | +50.8% |
| Q3 2016 | $46,820,000 | +146212.5% | 660 | 0.0% | 0.06% | +150.0% |
| Q2 2016 | $32,000 | -99.9% | 660 | -34.0% | 0.03% | -35.0% |
| Q1 2016 | $63,310,000 | +56426.8% | 1,000 | 0.0% | 0.04% | -41.2% |
| Q4 2015 | $112,000 | +14.3% | 1,000 | -2.0% | 0.07% | -1.4% |
| Q3 2015 | $98,000 | – | 1,020 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 519,119 | $40,605,000 | 3.00% |
| First Light Asset Management, LLC | 236,958 | $18,535,000 | 2.16% |
| SECTOR GAMMA AS | 108,734 | $8,505,000 | 1.76% |
| Rock Springs Capital Management LP | 646,841 | $50,596,000 | 1.39% |
| Atika Capital Management LLC | 79,000 | $6,180,000 | 0.80% |
| Capital Impact Advisors, LLC | 30,582 | $2,392,000 | 0.80% |
| FEDERATED HERMES, INC. | 4,080,359 | $319,166,000 | 0.79% |
| Rhenman & Partners Asset Management AB | 61,500 | $4,811,000 | 0.52% |
| Ikarian Capital, LLC | 73,500 | $5,749,000 | 0.46% |
| Capital International, Inc./CA/ | 477,858 | $37,378,000 | 0.46% |